Original language | English |
---|---|
Pages (from-to) | 1-18 |
Journal | Viruses |
State | Published - Dec 31 2020 |
Lead SARS-CoV-2 Candidate Vaccines: Expectations from Phase III Trials and Recommendations Post-Vaccine Approval
Research output: Contribution to journal › Article › peer-review